Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.55
-0.50 (-2.62%)
At close: Jul 31, 2026, 4:00 PM EDT
18.60
+0.05 (0.27%)
After-hours: Jul 31, 2026, 7:48 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.59 billion as of July 31, 2026. Its market cap has decreased by -51.82% in one year.
Market Cap
3.59B
Enterprise Value
3.14B
1-Year Change
-51.82%
Ranking
Category
Stock Price
$18.55
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.59B, a decrease of -25.03%. That is a compound annual growth rate of -4.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 3.59B | -10.63% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 3.91B |
| Denali Therapeutics | 3.85B |
| Viking Therapeutics | 3.79B |
| Enliven Therapeutics | 3.77B |
| Alumis | 3.63B |
| Arcus Biosciences | 3.55B |
| Structure Therapeutics | 3.45B |
| IDEAYA Biosciences | 3.43B |